Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Vaccines|September 23, 2022
A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune ResponsesChristin Schmidt, Florian D Hastert, Julia Gerbeth, et al.Antiviral Research|November 28, 2015
Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitroChristine von Rhein, Tatjana Weidner, Lisa Henß, et al.Journal of Virology|August 30, 2019
Interference with SAMHD1 Restores Late Gene Expression of Modified Vaccinia Virus Ankara in Human Dendritic Cells and Abrogates Type I Interferon ExpressionKatja Sliva, Judith Martin, Christine von Rhein, et al.Transfusion|October 13, 2016
Inactivation and removal of Zika virus during manufacture of plasma-derived medicinal productsJohannes Blümel, Didier Musso, Sebastian Teitz, et al.Plos One|September 12, 2013
Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model systemBenjamin Kraus, Katrin Fischer, Sarah M Büchner, et al.The Journal of General Virology|April 8, 2021
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infectionLisa Henss, Arne Auste, Christoph Schürmann, et al.Virology Journal|September 2, 2016
Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entryLisa Henß, Simon Beck, Tatjana Weidner, et al.Experimental Dermatology|June 26, 2004
Establishment of a mouse xenograft model for mycosis fungoidesSonja Thaler, Angelika M Burger, Thomas Schulz, et al.The Journal of Infectious Diseases|December 13, 2019
Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV VaccineLisa Henss, Constanze Yue, Christine Von Rhein, et al.Antiviral Research|June 1, 2016
Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound librarySimon Beck, Lisa Henß, Tatjana Weidner, et al.Pageof 6